Clinical Trials Logo

Morbidly Adherent Placenta clinical trials

View clinical trials related to Morbidly Adherent Placenta.

Filter by:
  • None
  • Page 1

NCT ID: NCT05817448 Not yet recruiting - Hypoxia Clinical Trials

Hypoxia-induced Autophagy in the Pathogenesis of MAP

Start date: September 2023
Phase:
Study type: Observational

To investigate the role of HIF 1α and LC3B in the pathogenesis of MAP, to evaluate the role of MMP-9 in the antenatal prediction of MAP, and to compare the expression of HIF1α, LC3B, and level MMP-9 between patients of placenta previa with MAP and patients with normal placentation.

NCT ID: NCT05307016 Recruiting - Clinical trials for Morbidly Adherent Placenta

Morbidly Adherent Placenta, Diagnosis and Proper Management

Start date: February 1, 2022
Phase:
Study type: Observational

The main idea of this study is to establish the diagnostic criteria for cases of morbidly adherent placenta (MAP) using different ultrasonographic modalities and compare this with intra-operative findings and postoperative histopathological assessment

NCT ID: NCT04938050 Recruiting - Clinical trials for Morbidly Adherent Placenta

Diagnostic Accuracy of a Specialized Pro Forma in Assessing Morbidly Adherent Placenta With Correlation to Intra-operative Findings

Start date: June 18, 2021
Phase:
Study type: Observational

This study objective is to assess the accuracy of a specialized pro forma in suggesting the probability of Morbidly Adherent Placenta, its extent and its correlation with intraoperative findings.

NCT ID: NCT03976453 Completed - Clinical trials for Morbidly Adherent Placenta

Psychological Outcome of Women With Morbidly Adherent Placenta Following Hystrectomy

Start date: June 15, 2019
Phase:
Study type: Observational

The purpose of this study is to investigate the risk of postoperative psychiatric disorders of depression, anxiety outcomes and sexual dysfunctions and self esteem disturbance in women with morbidly adherent placenta following hysterectomy. Research hypothesis: In women with morbidly adherent placenta, We will predict, evaluate and decrease the psychological disorders following hysterectomy. Research question: Is there any difference in psychological outcome between caesarean section and caesarean hysterectomy ? This study aims to assess the psychological outcome in women with morbidly adherent placenta following hysterectomy.

NCT ID: NCT03676855 Recruiting - Clinical trials for Morbidly Adherent Placenta

Comparison Between Bladder Dissection Before and After Uterine Incision in Cesarean Section for Morbidly Adherent Placenta

Start date: March 31, 2018
Phase: N/A
Study type: Interventional

Comparison between bladder dissection at the beginning of cesarean section For morbidly adherent placenta and between delaying dissection until planning for cesarean hysterectomy

NCT ID: NCT03416296 Completed - Clinical trials for Morbidly Adherent Placenta

Role of Ultrasound in Diagnosis of Placenta Previa and MAP

Start date: March 15, 2018
Phase:
Study type: Observational

Placenta accreta occurs when the placental implantation is abnormal. The marked rise in incidence has been assumed the increasing prevalence of cesarean delivery in recent years.

NCT ID: NCT02784886 Active, not recruiting - Placenta Accreta Clinical Trials

Cell-free Fetal DNA Circulating in the Maternal Plasma as a Marker for Morbidly Adherent Placenta

DNA-Accreta
Start date: November 2013
Phase: N/A
Study type: Observational

The purpose of this study is to determine whether, in a high risk population (placenta praevia and previous caesarean or prenatal suspicion of morbidly adherent placenta (MAP)), the concentration of cell-free fetal DNA circulating in the maternal plasma is significantly increased in the subgroup of morbidly adherent placenta (MAP) cases , in order to determine if the dosage of cell-free fetal DNA circulating in the maternal plasma may be a useful biological tool to detect MAP, alone or in addition to the imagery findings (ultrasonography and RMI).

NCT ID: NCT02635412 Withdrawn - Placenta Accreta Clinical Trials

Delivery Timing in Morbidly Adherent Placentas: a Randomized, Controlled Trial

MAP
Start date: March 2016
Phase: N/A
Study type: Interventional

This is a randomized controlled trial to investigate the optimal timing of delivery in clinically stable women with a suspected morbidly adherent placenta.